IL17A and Hepatic fibrosis: There was a significant decrease in the protein levels of TNFα, IL‐6 and IL‐17 (P < 0.01) in CCI4 treated fibrosis‐induced mice injected with Exo‐181 compared to the liver fibrosis mouse model without exosome treatment (Fig. 6C).